We just received data on a new analyst forecast for $RARE. HC Wainwright & Co. gave a rating of 'Buy' for $RARE.
$RARE Analyst Ratings
Wall Street analysts have issued reports on $RARE in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 07/28/2025
- Morgan Stanley issued a "Overweight" rating on 07/14/2025
- Guggenheim issued a "Buy" rating on 06/20/2025
- William Blair issued a "Outperform" rating on 05/28/2025
- JP Morgan issued a "Overweight" rating on 03/27/2025
- Piper Sandler issued a "Overweight" rating on 03/17/2025
- Cantor Fitzgerald issued a "Overweight" rating on 02/26/2025
To track analyst ratings and price targets for $RARE, check out Quiver Quantitative's $RARE forecast page.
$RARE Price Targets
Multiple analysts have issued price targets for $RARE recently. We have seen 11 analysts offer price targets for $RARE in the last 6 months, with a median target of $80.0.
Here are some recent targets:
- Raghuram Selvaraju from HC Wainwright & Co. set a target price of $80.0 on 07/28/2025
- Laura Chico from Wedbush set a target price of $34.0 on 07/14/2025
- Jeffrey Hung from Morgan Stanley set a target price of $55.0 on 07/14/2025
- Tiago Fauth from Wells Fargo set a target price of $65.0 on 07/10/2025
- Debjit Chattopadhyay from Guggenheim set a target price of $64.0 on 06/20/2025
- Sami Corwin from William Blair set a target price of $65.0 on 05/28/2025
- Anupam Rama from JP Morgan set a target price of $117.0 on 03/27/2025
$RARE Insider Trading Activity
$RARE insiders have traded $RARE stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $RARE stock by insiders over the last 6 months:
- EMIL D KAKKIS (President & CEO) has made 0 purchases and 2 sales selling 98,434 shares for an estimated $4,153,571.
- KARAH HERDMAN PARSCHAUER (EVP and Chief Legal Officer) has made 0 purchases and 3 sales selling 15,836 shares for an estimated $669,040.
- ERIK HARRIS (EVP & Chief Commercial Officer) sold 15,103 shares for an estimated $635,836
- JOHN RICHARD PINION (See Remarks) sold 14,439 shares for an estimated $607,881
- ERIC CROMBEZ (EVP and Chief Medical Officer) has made 0 purchases and 3 sales selling 9,707 shares for an estimated $405,485.
- THOMAS RICHARD KASSBERG (CBO & EVP) sold 6,028 shares for an estimated $253,778
- CORAZON (CORSEE) D. SANDERS sold 2,405 shares for an estimated $89,922
- HOWARD HORN (Chief Financial Officer) sold 1,785 shares for an estimated $72,114
- THEODORE ALAN HUIZENGA (SVP, Chief Accounting Officer) sold 967 shares for an estimated $40,710
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RARE Hedge Fund Activity
We have seen 156 institutional investors add shares of $RARE stock to their portfolio, and 140 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VESTAL POINT CAPITAL, LP removed 1,000,000 shares (-66.7%) from their portfolio in Q1 2025, for an estimated $36,210,000
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 965,919 shares (+81.6%) to their portfolio in Q1 2025, for an estimated $34,975,926
- ASSENAGON ASSET MANAGEMENT S.A. added 947,865 shares (+439.0%) to their portfolio in Q2 2025, for an estimated $34,464,371
- SUVRETTA CAPITAL MANAGEMENT, LLC added 873,186 shares (+75.8%) to their portfolio in Q1 2025, for an estimated $31,618,065
- MARSHALL WACE, LLP removed 717,495 shares (-68.2%) from their portfolio in Q1 2025, for an estimated $25,980,493
- PRICE T ROWE ASSOCIATES INC /MD/ added 706,519 shares (+28.1%) to their portfolio in Q1 2025, for an estimated $25,583,052
- DEEP TRACK CAPITAL, LP added 696,487 shares (+106.6%) to their portfolio in Q1 2025, for an estimated $25,219,794
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
